Stock Report

Download full stock data and analysis for free Last Updated: 28-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

AIM ImmunoTech (AIM) Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.25

up-down-arrow $0.16 (163.44%)

As on 27-Aug-2026 16:10EDT

Market cap

info icon

$8 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.9

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 18.18 4.00 -21.49 -14.54 -11.60
EBIT -28.47 -32.06 15.60 9.81 0.83
Net Profit -25.31 -35.58 11.73 8.64 0.61
EPS 68.15 83.42 59.02 20.18 11.39
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -----13,823.16-14,938.64-9,844.12
Net Margin info -----15,021.05----
Return on equity info ------251.38-388.69
Return on Capital info ------854.22-275.55
Return on Assets info -----75.73-194.00-123.60
Debt to Equity (x) info ----0.00-0.50-2.22

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
--
854.22
-275.55
-264.44
-115.26
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
--
251.38
-388.69
-283.00
-118.94
Peer Median
-40.29
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-75.73

Lower than Peers by 44.90

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
-75.73
-194.00
-123.60
-149.15
-96.75
Peer Median
-30.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-13,823.16

Lower than Peers by 13,740.95

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
-13,823.16
-14,938.64
-9,844.12
-15,793.07
-14,337.62
Peer Median
-82.21
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-15,021.05

Lower than Peers by 14,931.17

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
-15,021.05
-15,861.36
-10,188.24
-14,337.62
-14,337.62
Peer Median
-89.88
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

-0.11

Lower than Peers by 0.11

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
-0.11
--
--
--
--
Peer Median
0.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-21.49

Lower than Peers by 75.52

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
-21.49
-0.48
-0.16
0.43
0.43
Peer Median
54.03
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

15.60

Higher than Peers by 16.55

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
15.60
21.45
42.22
-60.13
-48.94
Peer Median
-0.95
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

11.73

Higher than Peers by 18.91

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
11.73
19.41
40.20
-37.35
-48.94
Peer Median
-7.19
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

59.02

Higher than Peers by 44.59

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
59.02
0.59
-17.74
--
0.96
Peer Median
14.43
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

114.47

Higher than Peers by 124.93

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
114.47
--
--
--
--
Peer Median
-10.46
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
--
-0.50
-2.22
0.07
0.07
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.50

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
0.50
-0.39
-1.93
0.02
0.02
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

2.11

Lower than Peers by 3.70

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
2.11
0.53
0.44
1.68
1.68
Peer Median
5.80
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

2.11

Lower than Peers by 3.58

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
2.11
--
--
--
1.72
Peer Median
5.69
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-11.54

Lower than Peers by 9.45

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
-11.54
-16.19
-28.61
--
--
Peer Median
-2.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
--
7.95
--
586.14
586.14
Peer Median
18.97
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.01

Lower than Peers by 0.06

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
0.01
0.01
0.01
0.01
0.01
Peer Median
0.07
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
--
29.05
2,543.86
2,140.87
2,585.68
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
--
--
--
--
-2,626.32
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
--
4,329.51
75,559.62
8,404.66
29,654.82
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
--
--
--
--
-29,695.46
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
--
--
-0.02
--
-0.75
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.94

Lower than Peers by 4.41

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
0.94
--
-0.23
--
2.11
Peer Median
5.35
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

0.49

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
0.49
--
0.04
0.39
-0.32
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

8

Lower than Peers by 140

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Jan-24
Dec-23
AIM ImmunoTech (AIM)
8
--
--
--
--
Peer Median
147
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...